Aspire Biopharma (ASBP) appoints Michael Howe as CEO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. PTC
4. SPY
5. META
6. MSFT
7. GOOGL
8. GMAB
9. AMD
10. BBIO

Go back to Aspire Biopharma (ASBP) appoints Michael Howe as CEO

Aspire Biopharma Holdings, Inc., Announces Michael C. Howe - With Decades of Experience at Leading and Building Brands in the Healthcare and Consumer Space - To Be Its New Chief Executive Officer

June 10, 2025 8:31 AM EDT

Michael Howe - who currently serves as an Independent Board Member - to assume CEO role on June 10, 2025

Michael's career spans nationally recognized brands such as MinuteClinic, Procter & Gamble, PepsiCo, CEO of Arby's, and as an early-stage investor/board member in healthcare and software businesses

HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq: ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug... More